NCT06537804

Brief Summary

One thousand randomly selected voluntary citizens aged 60-74 years old, who are heavy current or former smokers with an increased risk of developing lung cancer may be included in the project. The participants will be identified through an initial questionnaire survey concerning smoking history and general health. Project participants are offered a low-dose CT (LDCT) scan annually for three consecutive years. In relation to the first scan, a lung function test will also be performed. The screening process will be evaluated for possible national implementation of a lung cancer screening program in Denmark.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,332

participants targeted

Target at P75+ for not_applicable lung-cancer

Timeline
7mo left

Started Aug 2024

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Aug 2024Dec 2026

First Submitted

Initial submission to the registry

July 1, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 5, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

August 5, 2024

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

April 15, 2025

Status Verified

April 1, 2025

Enrollment Period

2.4 years

First QC Date

July 1, 2024

Last Update Submit

April 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Lung cancer screening cost-effectiveness analysis quantified in the form of incremental cost-effectiveness ratio threshold

    ratio

    Up to 36 months

Secondary Outcomes (19)

  • Characteristics of citizens from the cohort based on registry data

    Up to 36 months

  • Participation rate

    36 months (complete study period)

  • Dropouts

    36 months (complete study period)

  • Lung cancer found on low dose CT-scans

    Baseline, after 1 year, after 2 years

  • Inconclusive or non-malignant findings on low dose CT scans

    Baseline, after 1 year, after 2 years

  • +14 more secondary outcomes

Study Arms (2)

Intervention

OTHER

Low-dose CT scans are performed once a year from 2024 to 2026 to screen for lung cancer including a lung function test the first year of attendance (2024).

Radiation: Screening by low-dose CT scan

Control

NO INTERVENTION

Citizens from the cohort who are randomized to no intervention.

Interventions

Screening for lung cancer by low-dose CT scan

Intervention

Eligibility Criteria

Age60 Years - 74 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Heavy smokers (≥ 30 pack years) or citizens with a PLCOm2012 calculated 6-year risk of lung cancer \> 2%.
  • Age: 60-74 years old
  • Residence on Funen and surrounding islands

You may not qualify if:

  • Cancer treatment or follow-up (except non melanoma skin cancer and similar low malignant cancers) within the past 12 months
  • CT scan performed within the past 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Odense University Hospital

Odense, Region Syddanmark, 5000, Denmark

Location

Department of Radiology, Svendborg Hospital

Svendborg, Region Syddanmark, 5700, Denmark

Location

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Michael Stenger, Consultant

    Odense University Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2024

First Posted

August 5, 2024

Study Start

August 5, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 15, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations